V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10374740 | 10040312 | 1.67 | 84 | Palliative (P) | 2014-05-30 | 2014-08-09 | Folfirinox | 02 | N | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 101676836 |
| 10374793 | 10040313 | 1.73 | 78 | Adjuvant (A) | 2021-04-04 | 2021-04-04 | null | 02 | N | CISPLATIN + FLUOROURACIL | 101298061 |
| 10374796 | 10040314 | 1.77 | 42 | Adjuvant (A) | 2019-05-12 | 2019-05-15 | Fluorouricil + Folonic Acid (MdG) | null | null | FLUOROURACIL | 100394503 |
| 10374886 | 10040318 | 1.63 | 55.3 | Palliative (P) | 2015-11-10 | 2015-12-14 | Venetoclax | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL | 101053096 |
| 10374891 | 10040319 | 1.56 | 67.05 | null | 2019-01-21 | 2019-01-21 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100015650 |
| 10374899 | 10040321 | 1.54 | 79 | null | 2019-12-23 | 2019-12-23 | Pazopanib | Y | Y | BUSULFAN | 101121401 |
| 10374966 | 10040322 | 1.62 | 60.3 | Curative (C) | 2019-02-18 | 2019-02-18 | CHOP - 21 days | 02 | N | PAZOPANIB | 101219231 |
| 10374998 | 10040323 | 1.52 | 59.9 | Palliative (P) | 2019-01-13 | 2019-01-17 | Avelumab | 02 | N | AVELUMAB | 100417615 |
| 10375040 | 10040324 | 1.62 | 77.15 | Palliative (P) | 2018-03-11 | 2018-03-19 | CISPLATIN + FLUOROURACIL | 02 | N | FLUOROURACIL | 100184254 |
| 10375054 | 10040325 | null | null | null | 2019-03-03 | 2019-03-03 | CHLORAMBUCIL + RITUXIMAB | N | null | CHLORAMBUCIL + RITUXIMAB | 100044271 |
| 10375063 | 10040326 | 1.66 | 49.6 | Curative (C) | 2018-11-12 | 2018-11-22 | Bortezomib +/- Dexamethasone | N | null | BORTEZOMIB | 100396731 |
| 10375153 | 10040327 | 1.74 | 0.1 | Adjuvant (A) | 2020-01-11 | 2020-01-17 | Palbociclib | 02 | null | PALBOCICLIB | 101125657 |
| 10375198 | 10040329 | 1.79 | 76.4 | Palliative (P) | 2017-07-29 | 2017-07-29 | BORTEZOMIB + THALIDOMIDE | 02 | N | BORTEZOMIB + THALIDOMIDE | 101712636 |
| 10375266 | 10040330 | 0 | 0 | null | 2019-06-08 | 2019-06-09 | Capecitabine + Cisplatin + RT | 02 | null | CYCLOPHOSPHAMIDE + THALIDOMIDE | 101623576 |
| 10375273 | 10040331 | 1.59 | 57.2 | null | 2016-05-19 | 2016-05-26 | Venetoclax | 02 | null | BUSULFAN | 101120468 |
| 10375315 | 10040333 | 1.55 | 97.85 | null | 2019-09-15 | 2019-09-30 | MITOMYCIN | 02 | Y | CYTARABINE | 101235865 |
| 10375362 | 10040334 | 1.85 | null | 03 | 2018-10-21 | 2018-10-28 | FEC 100 | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100850974 |
| 10375472 | 10040335 | 1.61 | 88.8 | Adjuvant (A) | 2017-04-21 | 2017-05-08 | Avelumab | 02 | N | AVELUMAB | 101586051 |
| 10375571 | 10040336 | 1.76 | 63 | null | 2019-02-04 | 2019-02-04 | FEC 60 or 75 | 2 | Y | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100761974 |
| 10375595 | 10040338 | null | 0 | Palliative (P) | 2019-11-13 | 2019-11-25 | Avelumab | 02 | N | AVELUMAB | 100170394 |
| 10375638 | 10040339 | 1.72 | 73.7 | null | 2017-03-03 | 2017-03-14 | FEC + DOCETAXEL | N | null | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | 101862628 |
| 10375692 | 10040340 | null | null | null | 2018-07-06 | 2018-07-06 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | N | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 100519323 |
| 10375888 | 10040344 | 1.67 | 85.4 | Palliative (P) | null | 2018-07-27 | POMALIDOMIDE | 02 | null | CYCLOPHOSPHAMIDE + DOCETAXEL | 101436414 |
| 10375896 | 10040345 | 1.69 | 81 | null | 2018-10-28 | 2018-10-28 | null | 02 | null | CYCLOPHOSPHAMIDE + RITUXIMAB | 101489269 |
| 10375996 | 10040347 | 1.58 | 63 | Palliative (P) | 2019-10-08 | 2019-10-13 | Cyclophosphamide + Docetaxel | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL | 100774346 |
| 10376027 | 10040349 | 1.61 | 75.2 | Palliative (P) | 2017-12-15 | 2017-12-23 | CYTARABINE | 02 | N | CAPECITABINE + CISPLATIN | 100112954 |
| 10376078 | 10040351 | 1.62 | 67.4 | Curative (C) | 2018-11-13 | 2018-11-27 | CVP R | 02 | N | DARATUMUMAB | 100393346 |
| 10376116 | 10040352 | 0 | 0 | Palliative (P) | 2018-06-24 | 2018-07-11 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101505146 |
| 10376119 | 10040353 | 1.74 | 79.4 | Curative (C) | 2017-12-21 | 2017-12-29 | FLUOROURACIL + IRINOTECAN | 02 | null | FLUOROURACIL + IRINOTECAN | 100149193 |
| 10376190 | 10040355 | 1.63 | 70.2 | null | 2020-01-24 | 2020-01-24 | MITOMYCIN | 02 | null | CYCLOPHOSPHAMIDE + DOCETAXEL | 101252686 |
| 10376193 | 10040356 | 1.57 | null | null | 2020-03-01 | 2020-03-07 | DABRAFENIB + TRAMETINIB | 02 | null | SUNITINIB | 100531415 |
| 10376297 | 10040357 | 1.59 | 66 | Curative (C) | 2017-08-03 | 2017-10-20 | Bortezomib +/- Dexamethasone | 01 | null | BORTEZOMIB | 101744442 |
| 10376417 | 10040358 | null | 0 | null | 2018-03-01 | 2018-04-05 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | null | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 101809076 |
| 10376546 | 10040360 | 1.71 | 98.35 | Palliative (P) | 2011-11-16 | 2018-06-22 | Carboplatin + Pembrolizumab + Pemetrexed | 02 | N | DABRAFENIB + TRAMETINIB | 101359054 |
| 10376557 | 10040362 | 1.78 | null | Palliative (P) | 2018-08-02 | 2018-08-02 | BORTEZOMIB + THALIDOMIDE | 02 | N | BORTEZOMIB + THALIDOMIDE | 101237932 |
| 10376663 | 10040363 | 1.67 | 69 | null | 2019-03-24 | 2019-03-31 | CHOP - 21 days | null | null | CAPECITABINE + CISPLATIN | 100562278 |
| 10376723 | 10040365 | 1.84 | 99.8 | null | 2018-07-25 | 2018-07-25 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100874756 |
| 10376736 | 10040366 | 1.53 | 58.5 | 03 | 2018-09-14 | 2018-09-20 | CYTARABINE | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 100207059 |
| 10376754 | 10040367 | 1.63 | 71.5 | Neo-adjuvant (N) | 2019-01-25 | 2019-02-10 | CYTARABINE | 02 | null | CISPLATIN + VINORELBINE | 101865240 |
| 10376763 | 10040368 | 1.7 | 99 | null | 2019-05-23 | 2019-06-06 | R Chlorambucil | 02 | null | CHLORAMBUCIL + RITUXIMAB | 100238943 |
| 10376852 | 10040369 | 1.53 | 115 | 03 | 2018-07-15 | 2018-07-25 | Cyclophosphamide + Docetaxel | 02 | N | CVP R | 101320080 |
| 10376921 | 10040371 | 1.77 | 58.2 | Adjuvant (A) | 2018-03-13 | 2018-03-20 | R Chlorambucil | 02 | N | CHLORAMBUCIL + RITUXIMAB | 100507413 |
| 10376966 | 10040372 | 1.63 | 58.5 | 03 | 2017-06-12 | 2017-06-26 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 02 | N | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 101021315 |
| 10377084 | 10040374 | 1.72 | null | null | 2017-03-17 | 2017-03-17 | CYCLOPHOSPHAMIDE + RITUXIMAB + Dexamethasone | 02 | N | CAPECITABINE + GEMCITABINE | 100102566 |
| 10377090 | 10040375 | 1.79 | null | Palliative (P) | 2021-09-07 | 2021-09-13 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 100844275 |
| 10377123 | 10040376 | 1.61 | 70.8 | Palliative (P) | 2019-10-22 | 2019-11-11 | CARBOPLATIN + VINORELBINE | N | N | CARBOPLATIN + VINORELBINE | 101847663 |
| 10377213 | 10040379 | null | 0 | 03 | 2017-03-04 | 2017-04-12 | POMALIDOMIDE | 02 | N | CYTARABINE | 101481969 |
| 10377305 | 10040380 | 1.62 | 71.1 | null | 2019-09-02 | 2019-09-09 | CYCLOPHOSPHAMIDE + RITUXIMAB | 02 | null | POMALIDOMIDE | 100086118 |
| 10377446 | 10040382 | 1.61 | 68.5 | Palliative (P) | 2016-11-17 | 2016-11-30 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 02 | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101832740 |
| 10377474 | 10040383 | null | 0 | null | 2020-02-27 | 2020-03-02 | NIVOLUMAB | 02 | null | NIVOLUMAB | 101627614 |